Suppr超能文献

肿瘤坏死因子介导的纤溶酶原激活物抑制剂2型基因表达调控的分子机制

Molecular mechanisms governing tumor-necrosis-factor-mediated regulation of plasminogen-activator inhibitor type-2 gene expression.

作者信息

Dear A E, Shen Y, Rüegg M, Medcalf R L

机构信息

Monash University Department of Medicine, Boxhill Hospital, Victoria, Australia.

出版信息

Eur J Biochem. 1996 Oct 1;241(1):93-100. doi: 10.1111/j.1432-1033.1996.0093t.x.

Abstract

Plasminogen-activator inhibitor type 2 (PAI-2), a serine protease inhibitor involved in the regulation of urokinase-dependent proteolysis, is also implicated in the inhibition of tumor-necrosis-factor-(TNF)-mediated apoptosis. The PAI-2 gene is one of the most TNF-responsive genes known and is also highly induced by the phorbol ester phorbol 12-myristate 13-acetate (PMA) and the phosphatase inhibitor, okadaic acid, in both HT-1080 fibrosarcoma and U-937 histiocytic cells. We sought to identify and characterize regulatory cis-acting DNA elements and trans-acting factors which mediate basal and inducible PAI-2 gene transcription. A series of promoter deletion mutants (nucleotides -1859 to -91) fused to the chloramphenicol acetyl transferase (CAT) reporter gene were transfected into HT-1080 cells. Two repressor regions were identified; one distally between positions -1859 and -1100, and one proximally between positions -259 and -219. Cells transfected with constructs harboring more than 259 bp promoter sequence produced a 10-15-fold increase in CAT activity when treated with PMA or okadaic acid, but produced only a minimal (2.5-fold) increase in response to TNF. Removal of the proximal repressor by deletion to position -219, or by internal deletion from the -1100 PAI-2 CAT construct, resulted in a selective increase in TNF responsiveness, suggesting that induction of PAI-2 gene transcription by TNF is associated with derepression. Detailed analysis of the proximal repressor utilizing the electrophoretic mobility shift assay (EMSA), identified two novel and distinct protein-binding sites (A and B). Site A is located within the 40-bp proximal repressor while site B is situated immediately adjacent to the 3' boundary. Treatment of cells with PMA or okadaic acid produced no change in the binding activity of proteins recognising sites A or B. However, treatment of cells with TNF results in a profound selective reduction in site-B-binding activity, suggesting that this site plays a significant role in TNF-mediated regulation of PAI-2 gene expression. Our findings suggest that TNF-mediated induction of PAI-2 gene expression involves derepression and is associated with cis-acting and trans-acting factors located within and adjacent to the proximal repressor region.

摘要

纤溶酶原激活物抑制剂2(PAI - 2)是一种参与调节尿激酶依赖性蛋白水解的丝氨酸蛋白酶抑制剂,也与抑制肿瘤坏死因子(TNF)介导的细胞凋亡有关。PAI - 2基因是已知对TNF反应最敏感的基因之一,在HT - 1080纤维肉瘤细胞和U - 937组织细胞中,它也受到佛波酯佛波醇12 - 肉豆蔻酸酯13 - 乙酸酯(PMA)和磷酸酶抑制剂冈田酸的高度诱导。我们试图鉴定和表征介导基础和诱导性PAI - 2基因转录的顺式作用DNA元件和反式作用因子。将一系列与氯霉素乙酰转移酶(CAT)报告基因融合的启动子缺失突变体(核苷酸-1859至-91)转染到HT - 1080细胞中。鉴定出两个阻遏区域;一个在远端,位于-1859和-1100位之间,另一个在近端,位于-259和-219位之间。用含有超过259 bp启动子序列的构建体转染的细胞,在用PMA或冈田酸处理时,CAT活性增加10 - 15倍,但对TNF的反应仅产生最小的(2.5倍)增加。通过缺失到-219位或从-1100 PAI - 2 CAT构建体进行内部缺失去除近端阻遏物,导致TNF反应性选择性增加,这表明TNF诱导PAI - 2基因转录与去阻遏有关。利用电泳迁移率变动分析(EMSA)对近端阻遏物进行详细分析,鉴定出两个新的且不同的蛋白质结合位点(A和B)。位点A位于40 bp近端阻遏物内,而位点B紧邻3'边界。用PMA或冈田酸处理细胞不会改变识别位点A或B的蛋白质的结合活性。然而,用TNF处理细胞会导致位点B结合活性显著选择性降低,这表明该位点在TNF介导的PAI - 2基因表达调节中起重要作用。我们的研究结果表明,TNF介导的PAI - 2基因表达诱导涉及去阻遏,并且与位于近端阻遏区域内和相邻的顺式作用和反式作用因子有关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验